An Investigation of a SARS-CoV-2 Omicron Variant Cluster Linked to Nightclubs, Kalasin Province, Thailand, December 2021
DOI:
https://doi.org/10.59096/osir.v16i4.263662Keywords:
COVID-19, SARS-CoV-2 Omicron variants, COVID-19 vaccines, disease outbreaksAbstract
In December 2021, an outbreak of the SARS-CoV-2 Omicron variant linked to two nightclubs was reported in Kalasin Province, Thailand. This outbreak investigation aimed to understand its epidemiological characteristics, identify sources of infection, assess vaccine effectiveness, and provide control measure recommendations. This study analyzed investigation reports, interviewed all confirmed/probable cases, engaged in active case findings, assessed vaccine effectiveness among high-risk contacts, and surveyed the nightclub environment. This study found 246 confirmed and 338 probable cases, with a median age of 29 years (quartile1–quartile3 25–38 years). Over 40% (271/584) of cases had received at least two doses of vaccination. No severe cases or deaths were reported. Index cases were a Thai couple who traveled from Belgium and visited a nightclub, where the disease spread to 75% (12/16) of nightclub workers before reaching communities. High-risk contacts who received a booster vaccination significantly reduced SARS-CoV-2 infection risk compared with unvaccinated. (vaccine effectiveness 87.5%, 95% confidence interval 59.5–96.1). One of the suspected nightclubs was air-conditioned, crowded, and lacked compliance with measures, which were potential factors contributing to the outbreak. This study strongly recommends that individuals receive booster doses of the SARS-CoV-2 vaccine. Nightclub owners should adhere to COVID-19 public health measures to prevent disease transmission to the communities.
References
Arora S, Grover V, Saluja P, Algarni YA, Saquib SA, Asif SM, et al. Literature review of Omicron: a grim reality amidst COVID-19. Microorganisms. 2022 Feb 16;10(2):451. doi:10.3390/microorganisms10020451.
World Health Organization. Tracking SARS-CoV-2 variants [Internet]. Geneva: World Health Organization; 2022 [cited 2022 Nov 28]. <https://www.who.int/activities/tracking-SARS-CoV-2-variants/>
Rajatanavin N, Tuangratananon T, Suphanchaimat R, Tangcharoensathien V. Responding to the COVID-19 second wave in Thailand by diversifying and adapting lessons from the first wave. BMJ Glob Health. 2021;6(7):e006178. doi:10.1136/bmjgh-2021-006178.
Department of Medical Sciences. Thai National COVID-19 Surveillance Network [Internet]. Nonthaburi: Department of Medical Sciences; 2022 [cited 2022 Nov 28]. <https://tncn.dmsc.moph.go.th/>
World Health Organization. Enhancing response to Omicron SARS-CoV-2 variant [Internet]. Geneva: World Health Organization; 2022 Jan 21 [cited 2022 Nov 27]. 36 p. <https://www.who.int/publications/m/item/enhancing-readiness-for-omicron-(b.1.1.529)-technical-brief-and-priority-actions-for-member-states>
European Centre for Disease Prevention and Control. Methods for the detection and characterisation of SARS-CoV-2 variants: second update [Internet]. Stockholm: ECDC and WHO European Region; 2022 Aug 2 [cited 2022 Nov 28]. <https://www.ecdc.europa.eu/en/publications-data/methods-detection-and-characterisation-sars-cov-2-variants-second-update>
Royal Thai Government. Government News: COVID-19 Situations [Internet]. Bangkok: Royal Thai Government; 2022 [cited 2022 Nov 28]. <https://www.thaigov.go.th/news/contents/details/29299>
Department of Disease Control. Guidelines for Surveillance and Investigation of Coronavirus Disease 2019 (COVID-19) [Internet]. Nonthaburi: Department of Disease Control; 2021 [updated 2021 Dec 22, cited 2022 Nov 27]. 54 p. <https://ddc.moph.go.th/viralpneumonia/eng/file/guidelines/g_GSI_22Dec21.pdf>
Department of Health, Ministry of Public Health. COVID Free setting recommendation for the restaurant with alcohol sale [Internet]. Nonthaburi: Department of Health; 2021 [cited 2022 Nov 28]. <https://covid19.anamai.moph.go.th/th/covid-free-setting/>. Thai.
World Health Organization. Evaluation of COVID-19 vaccine effectiveness [Internet]. Geneva: World Health Organization: 2021 Mar 17 [cited 2022 Nov 8]. 70 p. <https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccine_effectiveness-measurement-2021.1>
Jara A, Undurraga EA, Gonzalez C, et al. Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile. N Engl J Med. 2021;385(10):875–84. doi:10.1056/NEJMOA2107715.
Wolter N, Jassat W, Walaza S, Welch R, Moultrie H, Groome M, et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022 Jan 29;399(10323):437–46. doi:10.1016/S0140-6736(22)00017-4.
Butt AA, Dargham SR, Coyle P, Yassine HM, Al-Khal A, Abou-Samra A, et al. COVID-19 disease severity in persons infected with Omicron BA.1 and BA.2 sublineages and association with vaccination status. JAMA Intern Med. 2022;182(10):1097–9. doi:10.1001/jamainternmed.2022.3351.
Wilhelm A, Widera M, Grikscheit K, Toptan T, Schenk B, Pallas C, et al. Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies. EBioMedicine. 2022 Aug; 82:104158. doi:10.1016/j.ebiom.2022.104158.
Eggink D, Andeweg SP, Vennema H, van Maarseveen N, Vermaas K, Vlaemynck B, et al. Increased risk of infection with SARS-CoV-2 Omicron BA.1 compared with Delta in vaccinated and previously infected individuals, the Netherlands, 22 November 2021 to 19 January 2022. Euro Surveill. 2022 Jan;27(4):2101196. doi:10.2807/1560-7917.ES.2022.27.4.2101196.
Zhao X, Shen Z, Sun L, Cheng L, Wang M, Zhang X, et al. A network meta-analysis of secondary attack rates of COVID-19 in different contact environments. Epidemiol Infect. 2021 Oct 5;149:e219. doi:10.1017/S0950268821002223.
Wu Y, Kang L, Guo Z, Liu J, Liu M, Liang W. Incubation period of COVID-19 caused by unique SARS-CoV-2 strains: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(8):e2228008. doi:10.1001/jamanetworkopen.2022.28008.
Van Goethem N, Chung PYJ, Meurisse M, Vandromme M, De Mot L, Brondeel R, et al. Clinical severity of SARS-CoV-2 Omicron variant compared with Delta among hospitalized COVID-19 patients in Belgium during autumn and winter season 2021-2022. Viruses. 2022 Jun 14;14(6):1297. doi:10.3390/v14061297.
Yang W, Yang S, Wang L, Zhou Y, Xin Y, Li H, et al. Clinical characteristics of 310 SARS-CoV-2 Omicron variant patients and comparison with Delta and Beta variant patients in China. Virol Sin. 2022 Oct;37(5):704–15. doi:10.1016/j.virs.2022.07.014.
European Centre for Disease Prevention and Control. Epidemiological update: Omicron variant of concern (VOC) – data as of 9 December 2021 (12:00) [Internet]. Stockholm: European Centre for Disease Prevention and Control; 2021 Dec 9 [2022 Nov 28]. <https://www.ecdc.europa.eu/en/news-events/epidemiological-update-omicron-data-9-december>
Duval D, Palmer JC, Tudge I, Pearce-Smith N, O’Connell E, Bennett A, et al. Long distance airborne transmission of SARS-CoV-2: rapid systematic review. BMJ. 2022 Jun 29;377:e068743. doi:10.1136/bmj-2021-068743.
Mahale P, Rothfuss C, Bly S, Kelley M, Bennett S, Huston SL, et al. Multiple COVID-19 outbreaks linked to a wedding reception in Rural Maine - August 7-September 14, 2020. MMWR Morb Mortal Wkly Rep. 2020 Nov 13;69(45):1686–90. doi:10.15585/mmwr.mm6945a5.
Ravindran B, Hogarth F, Williamson K, Wright R, Kirk M, Dalton C. High COVID-19 attack rate among attendees of wedding events in Bali, Indonesia, March 2020. Commun Dis Intell (2018). 2020 Sep 16:44. doi:10.33321/cdi.2020.44.76.
Muller N, Kunze M, Steitz F, Saad NJ, Muhlemann B, Beheim-Schwarzbach JI, et al. Severe acute respiratory syndrome coronavirus 2 outbreak related to a nightclub, Germany, 2020. Emerg Infect Dis. 2020 Feb;27(2):645–8. doi:10.3201/eid2702.204443.
Chenchula S, Karunakaran P, Sharma S, Chavan M. Current evidence on efficacy of COVID-19 booster dose vaccination against the Omicron variant: a systematic review. J Med Virol. 2022 Jul;94(7):2969–76. doi:10.1002/jmv.27697.
Garcia-Beltran WF, St Denis KJ, Hoelzemer A, Lam EC, Nitido AD, Sheehan ML, et al. mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant. Cell. 2022;185(3):457–466.e4. doi:10.1016/j.cell.2021.12.033.
Talic S, Shah S, Wild H, Gasevic D, Maharaj A, Ademi Z, et al. Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis. BMJ. 2021;375:e068302. doi:10.1136/bmj-2021-068302.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Outbreak, Surveillance, Investigation & Response (OSIR) Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
